Syndecan 4 is a marker of endothelial inflammation in pathological aging and predicts long-term cardiovascular outcomes in type 2 diabetes.
Endothelial dysfunction
Glycocalyx
Major cardiovascular adverse events
Syndecan 4
Type 2 diabetes
Journal
Diabetology & metabolic syndrome
ISSN: 1758-5996
Titre abrégé: Diabetol Metab Syndr
Pays: England
ID NLM: 101488958
Informations de publication
Date de publication:
20 Aug 2024
20 Aug 2024
Historique:
received:
14
06
2024
accepted:
24
07
2024
medline:
21
8
2024
pubmed:
21
8
2024
entrez:
20
8
2024
Statut:
epublish
Résumé
Endothelial cellular senescence is emerging as a key mechanism of age-related vascular dysfunction. Disruption of the endothelium glycocalyx and shedding of the syndecan (SDC) ectodomains have been associated with several age-related diseases. Although SDC4 is highly expressed in endothelial cells, its levels and shedding in senescent endothelial cells and vascular endothelial dysfunction associated with aging are still unknown. To assess whether SDC4 expression was affected by inflammatory conditions, we evaluated its levels in young human umbilical vein endothelial cells (HUVECs) treated with TNF-α at a concentration of 50 ng/mL for 24 h and in cells undergoing replicative senescence. Plasma levels of SDC4 were evaluated in two previously recruited cohorts of (i) subjects with type 2 diabetes (T2D, n = 110) followed for a median of 16.8 years and age- and gender-matched healthy subjects (n = 100), and (ii) middle-aged subjects with mild-to-moderate dyslipidemia. Binomial logistic regression was used to assess whether SDC4 levels could be prognostic for major adverse cardiovascular events (MACE). In the in vitro study, we showed that HUVECs, when exposed to TNF-α or undergoing replicative senescence, exhibited elevated expression levels of SDC4 and matrix metallopeptidase 9 (MMP-9), as well as increased shedding of SDC4 into the extracellular microenvironment, in comparison to actively proliferating young HUVECs. Analysis of human samples revealed that patients with T2D without complications exhibited higher SDC4 levels compared to healthy controls and those with T2D vascular complications. In particular, patients with a history of major adverse cardiovascular events (MACE) had lower SDC4 levels. The longitudinal evaluation revealed that higher SDC4 levels predict the onset of new MACE during a 16.8-year follow-up. In the second cohort, no significant association was observed between SDC4 and endothelial dysfunction, assessed by flow-mediated dilation (FMD) or nitric oxide metabolites. SDC4 levels correlated positively with C-reactive protein (CRP) in both cohorts and with PAI-1 in the cohort of patients with T2D. Overall, we conclude that the shedding of SDC4 from endothelial cells increases under acute (TNF-α treatment) and chronic (senescence) inflammatory conditions and that increased circulating SDC4 levels are associated with systemic inflammation in pathological aging.
Sections du résumé
BACKGROUND
BACKGROUND
Endothelial cellular senescence is emerging as a key mechanism of age-related vascular dysfunction. Disruption of the endothelium glycocalyx and shedding of the syndecan (SDC) ectodomains have been associated with several age-related diseases. Although SDC4 is highly expressed in endothelial cells, its levels and shedding in senescent endothelial cells and vascular endothelial dysfunction associated with aging are still unknown.
METHODS
METHODS
To assess whether SDC4 expression was affected by inflammatory conditions, we evaluated its levels in young human umbilical vein endothelial cells (HUVECs) treated with TNF-α at a concentration of 50 ng/mL for 24 h and in cells undergoing replicative senescence. Plasma levels of SDC4 were evaluated in two previously recruited cohorts of (i) subjects with type 2 diabetes (T2D, n = 110) followed for a median of 16.8 years and age- and gender-matched healthy subjects (n = 100), and (ii) middle-aged subjects with mild-to-moderate dyslipidemia. Binomial logistic regression was used to assess whether SDC4 levels could be prognostic for major adverse cardiovascular events (MACE).
RESULTS
RESULTS
In the in vitro study, we showed that HUVECs, when exposed to TNF-α or undergoing replicative senescence, exhibited elevated expression levels of SDC4 and matrix metallopeptidase 9 (MMP-9), as well as increased shedding of SDC4 into the extracellular microenvironment, in comparison to actively proliferating young HUVECs. Analysis of human samples revealed that patients with T2D without complications exhibited higher SDC4 levels compared to healthy controls and those with T2D vascular complications. In particular, patients with a history of major adverse cardiovascular events (MACE) had lower SDC4 levels. The longitudinal evaluation revealed that higher SDC4 levels predict the onset of new MACE during a 16.8-year follow-up. In the second cohort, no significant association was observed between SDC4 and endothelial dysfunction, assessed by flow-mediated dilation (FMD) or nitric oxide metabolites. SDC4 levels correlated positively with C-reactive protein (CRP) in both cohorts and with PAI-1 in the cohort of patients with T2D.
CONCLUSION
CONCLUSIONS
Overall, we conclude that the shedding of SDC4 from endothelial cells increases under acute (TNF-α treatment) and chronic (senescence) inflammatory conditions and that increased circulating SDC4 levels are associated with systemic inflammation in pathological aging.
Identifiants
pubmed: 39164788
doi: 10.1186/s13098-024-01431-8
pii: 10.1186/s13098-024-01431-8
doi:
Types de publication
Journal Article
Langues
eng
Pagination
203Subventions
Organisme : Università Politecnica delle Marche
ID : RSA Grant
Organisme : Ministero della Salute
ID : Ricerca corrente
Informations de copyright
© 2024. The Author(s).
Références
Alam TA, Seifalian AM, Baker D. A review of methods currently used for assessment of in vivo endothelial function. Eur J Vasc Endovasc Surg. 2005;29:269–76.
pubmed: 15694800
doi: 10.1016/j.ejvs.2004.12.019
American Diabetes Association Professional Practice. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2022. Diabetes Care. 2022;45:S17–38.
doi: 10.2337/dc22-S002
Baeyens N, Mulligan-Kehoe MJ, Corti F, Simon DD, Ross TD, Rhodes JM, Wang TZ, Mejean CO, Simons M, Humphrey J, Schwartz MA. Syndecan 4 is required for endothelial alignment in flow and atheroprotective signaling. Proc Natl Acad Sci U S A. 2014;111:17308–13.
pubmed: 25404299
pmcid: 4260558
doi: 10.1073/pnas.1413725111
Bonfigli AR, Spazzafumo L, Prattichizzo F, Bonafe M, Mensa E, Micolucci L, Giuliani A, Fabbietti P, Testa R, Boemi M, Lattanzio F, Olivieri F. Leukocyte telomere length and mortality risk in patients with type 2 diabetes. Oncotarget. 2016;7:50835–44.
pubmed: 27437767
pmcid: 5239440
doi: 10.18632/oncotarget.10615
Chala N, Moimas S, Giampietro C, Zhang X, Zambelli T, Exarchos V, Nazari-Shafti TZ, Poulikakos D, Ferrari A. Mechanical fingerprint of senescence in endothelial cells. Nano Lett. 2021;21:4911–20.
pubmed: 34081865
doi: 10.1021/acs.nanolett.1c00064
Chia PY, Teo A, Yeo TW. Overview of the assessment of endothelial function in humans. Front Med. 2020;7: 542567.
doi: 10.3389/fmed.2020.542567
De Luca M, Bryan DR, Hunter GR. Circulating levels of the heparan sulfate proteoglycan syndecan-4 positively associate with blood pressure in healthy premenopausal women. Biomolecules. 2021;11(3):342.
pubmed: 33668381
pmcid: 7996250
doi: 10.3390/biom11030342
De Luca M, Bryan DR, Hunter GR. Serum syndecan-4 correlates with blood pressure and cardiovascular parameters but not proinflammatory markers in healthy older women. Aging Clin Exp Res. 2022;34:2541–5.
pubmed: 35932401
pmcid: 10122834
doi: 10.1007/s40520-022-02210-z
De Rossi G, Vahatupa M, Cristante E, Arokiasamy S, Liyanage SE, May U, Pellinen L, Uusitalo-Jarvinen H, Bainbridge JW, Jarvinen TAH, Whiteford JR. Pathological angiogenesis requires syndecan-4 for efficient VEGFA-induced VE-cadherin internalization. Arterioscler Thromb Vasc Biol. 2021;41:1374–89.
pubmed: 33596666
pmcid: 7613699
doi: 10.1161/ATVBAHA.121.315941
Echtermeyer F, Streit M, Wilcox-Adelman S, Saoncella S, Denhez F, Detmar M, Goetinck P. Delayed wound repair and impaired angiogenesis in mice lacking syndecan-4. J Clin Invest. 2001;107:R9–14.
pubmed: 11160142
pmcid: 199172
doi: 10.1172/JCI10559
Esposito S, Bianchini S, Gambino M, Madini B, Di Pietro G, Umbrello G, Presicce ML, Ruggiero L, Terranova L, Principi N. Measurement of lipocalin-2 and syndecan-4 levels to differentiate bacterial from viral infection in children with community-acquired pneumonia. BMC Pulm Med. 2016;16:103.
pubmed: 27439403
pmcid: 4955239
doi: 10.1186/s12890-016-0267-4
Farrugia BL, Lord MS, Melrose J, Whitelock JM. The role of heparan sulfate in inflammation, and the development of biomimetics as anti-inflammatory strategies. J Histochem Cytochem. 2018;66:321–36.
pubmed: 29290153
pmcid: 5958377
doi: 10.1369/0022155417740881
Foote CA, Soares RN, Ramirez-Perez FI, Ghiarone T, Aroor A, Manrique-Acevedo C, Padilla J, Martinez-Lemus L. Endothelial glycocalyx. Compr Physiol. 2022;12:3781–811.
pubmed: 35997082
pmcid: 10214841
doi: 10.1002/cphy.c210029
Guerrero F, Carmona A, Jimenez MJ, Obrero T, Pulido V, Moreno JA, Soriano S, Martin-Malo A, Aljama P. Passage number-induced replicative senescence modulates the endothelial cell response to protein-bound uremic toxins. Toxins. 2021;13:738.
pubmed: 34679030
pmcid: 8538293
doi: 10.3390/toxins13100738
Hadi HA, Carr CS, Al Suwaidi J. Endothelial dysfunction: cardiovascular risk factors, therapy, and outcome. Vasc Health Risk Manag. 2005;1:183–98.
pubmed: 17319104
pmcid: 1993955
Heo KS, Fujiwara K, Abe J. Shear stress and atherosclerosis. Mol Cells. 2014;37:435–40.
pubmed: 24781409
pmcid: 4086336
doi: 10.14348/molcells.2014.0078
Jaroszynski AJ, Jaroszynska A, Przywara S, Zaborowski T, Ksiazek A, Dabrowski W. Syndecan-4 Is an independent predictor of all-cause as well as cardiovascular mortality in hemodialysis patients. PLoS ONE. 2016;11: e0163532.
pubmed: 27685148
pmcid: 5042500
doi: 10.1371/journal.pone.0163532
Leite AR, Borges-Canha M, Cardoso R, Neves JS, Castro-Ferreira R, Leite-Moreira A. Novel biomarkers for evaluation of endothelial dysfunction. Angiology. 2020;71:397–410.
pubmed: 32077315
doi: 10.1177/0003319720903586
Li Y, Peng Z, Wang C, Li L, Leng Y, Chen R, Yuan H, Zhou S, Zhang Z, Chen AF. Novel role of PKR in palmitate-induced Sirt1 inactivation and endothelial cell senescence. Am J Physiol Heart Circ Physiol. 2018;315:H571–80.
pubmed: 29906232
doi: 10.1152/ajpheart.00038.2018
Lipphardt M, Dihazi H, Maas JH, Schafer AK, Amlaz SI, Ratliff BB, Koziolek MJ, Wallbach M. Syndecan-4 as a marker of endothelial dysfunction in patients with resistant hypertension. J Clin Med. 2020;9:3051.
pubmed: 32971813
pmcid: 7564403
doi: 10.3390/jcm9093051
Machin DR, Bloom SI, Campbell RA, Phuong TTT, Gates PE, Lesniewski LA, Rondina MT, Donato AJ. Advanced age results in a diminished endothelial glycocalyx. Am J Physiol Heart Circ Physiol. 2018;315:H531–9.
pubmed: 29750566
pmcid: 6172638
doi: 10.1152/ajpheart.00104.2018
Manon-Jensen T, Multhaupt HA, Couchman JR. Mapping of matrix metalloproteinase cleavage sites on syndecan-1 and syndecan-4 ectodomains. FEBS J. 2013;280:2320–31.
pubmed: 23384311
doi: 10.1111/febs.12174
McQuin C, Goodman A, Chernyshev V, Kamentsky L, Cimini BA, Karhohs KW, Doan M, Ding L, Rafelski SM, Thirstrup D, Wiegraebe W, Singh S, Becker T, Caicedo JC, Carpenter AE. Cell profiler 3.0: next-generation image processing for biology. PLoS Biol. 2018;16:2005970.
doi: 10.1371/journal.pbio.2005970
Mensa E, Guescini M, Giuliani A, Bacalini MG, Ramini D, Corleone G, Ferracin M, Fulgenzi G, Graciotti L, Prattichizzo F, Sorci L, Battistelli M, Monsurro V, Bonfigli AR, Cardelli M, Recchioni R, Marcheselli F, Latini S, Maggio S, Fanelli M, Amatori S, Storci G, Ceriello A, Stocchi V, De Luca M, Magnani L, Rippo MR, Procopio AD, Sala C, Budimir I, Bassi C, Negrini M, Garagnani P, Franceschi C, Sabbatinelli J, Bonafe M, Olivieri F. Small extracellular vesicles deliver miR-21 and miR-217 as pro-senescence effectors to endothelial cells. J Extracell Vesicles. 2020;9:1725285.
pubmed: 32158519
pmcid: 7048230
doi: 10.1080/20013078.2020.1725285
Miranda KM, Espey MG, Wink DA. A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite. Nitric Oxide. 2001;5:62–71.
pubmed: 11178938
doi: 10.1006/niox.2000.0319
Mockl L. The emerging role of the mammalian glycocalyx in functional membrane organization and immune system regulation. Front Cell Dev Biol. 2020;8:253.
pubmed: 32351961
pmcid: 7174505
doi: 10.3389/fcell.2020.00253
Okuyama E, Suzuki A, Murata M, Ando Y, Kato I, Takagi Y, Takagi A, Murate T, Saito H, Kojima T. Molecular mechanisms of syndecan-4 upregulation by TNF-alpha in the endothelium-like EAhy926 cells. J Biochem. 2013;154:41–50.
pubmed: 23576453
doi: 10.1093/jb/mvt024
Olivieri F, Prattichizzo F, Grillari J, Balistreri CR. Cellular senescence and inflammaging in age-related diseases. Mediators Inflamm. 2018;2018:9076485.
pubmed: 29849499
pmcid: 5932453
doi: 10.1155/2018/9076485
Palmer AK, Tchkonia T, LeBrasseur NK, Chini EN, Xu M, Kirkland JL. Cellular Senescence in type 2 diabetes: a therapeutic opportunity. Diabetes. 2015;64:2289–98.
pubmed: 26106186
pmcid: 4477358
doi: 10.2337/db14-1820
Prattichizzo F, De Nigris V, Sabbatinelli J, Giuliani A, Castano C, Parrizas M, Crespo I, Grimaldi A, Baranzini N, Spiga R, Mancuso E, Rippo MR, Procopio AD, Novials A, Bonfigli AR, Garavelli S, La Sala L, Matarese G, de Candia P, Olivieri F, Ceriello A. CD31(+) Extracellular vesicles from patients with type 2 diabetes shuttle a miRNA signature associated with cardiovascular complications. Diabetes. 2021;70:240–54.
pubmed: 33097483
doi: 10.2337/db20-0199
Ramnath R, Foster RR, Qiu Y, Cope G, Butler MJ, Salmon AH, Mathieson PW, Coward RJ, Welsh GI, Satchell SC. Matrix metalloproteinase 9-mediated shedding of syndecan 4 in response to tumor necrosis factor alpha: a contributor to endothelial cell glycocalyx dysfunction. FASEB J. 2014;28:4686–99.
pubmed: 25122554
doi: 10.1096/fj.14-252221
Ramnath RD, Butler MJ, Newman G, Desideri S, Russell A, Lay AC, Neal CR, Qiu Y, Fawaz S, Onions KL, Gamez M, Crompton M, Michie C, Finch N, Coward RJ, Welsh GI, Foster RR, Satchell SC. Blocking matrix metalloproteinase-mediated syndecan-4 shedding restores the endothelial glycocalyx and glomerular filtration barrier function in early diabetic kidney disease. Kidney Int. 2020;97:951–65.
pubmed: 32037077
pmcid: 7184681
doi: 10.1016/j.kint.2019.09.035
Sabbatinelli J, Castiglione S, Macrì F, Giuliani A, Ramini D, Vinci MC, Tortato E, Bonfigli AR, Olivieri F, Raucci A. Circulating levels of AGEs and soluble RAGE isoforms are associated with all-cause mortality and development of cardiovascular complications in type 2 diabetes: a retrospective cohort study. Cardiovasc Diabetol. 2022. https://doi.org/10.1186/s12933-022-01535-3 .
doi: 10.1186/s12933-022-01535-3
pubmed: 36088327
pmcid: 9463761
Sabbatinelli J, Giuliani A, Bonfigli AR, Ramini D, Matacchione G, Campolucci C, Ceka A, Tortato E, Rippo MR, Procopio AD, Moretti M, Olivieri F. Prognostic value of soluble ST2, high-sensitivity cardiac troponin, and NT-proBNP in type 2 diabetes: a 15-year retrospective study. Cardiovasc Diabetol. 2022;21:180.
pubmed: 36088327
pmcid: 9463761
doi: 10.1186/s12933-022-01616-3
Sabbatinelli J, Giuliani A, Kwiatkowska KM, Matacchione G, Belloni A, Ramini D, Prattichizzo F, Pellegrini V, Piacenza F, Tortato E, Bonfigli AR, Gentilini D, Procopio AD, Garagnani P, Olivieri F, Bronte G. DNA methylation-derived biological age and long-term mortality risk in subjects with type 2 diabetes. Cardiovasc Diabetol. 2024. https://doi.org/10.1186/s12933-024-02351-7 .
doi: 10.1186/s12933-024-02351-7
pubmed: 39003492
pmcid: 11245869
Sabbatinelli J, Orlando P, Galeazzi R, Silvestri S, Cirilli I, Marcheggiani F, Dludla PV, Giuliani A, Bonfigli AR, Mazzanti L, Olivieri F, Antonicelli R, Tiano L. Ubiquinol ameliorates endothelial dysfunction in subjects with mild-to-moderate dyslipidemia: a randomized clinical trial. Nutrients. 2020;12:1098.
pubmed: 32326664
pmcid: 7231284
doi: 10.3390/nu12041098
Schott U, Solomon C, Fries D, Bentzer P. The endothelial glycocalyx and its disruption, protection and regeneration: a narrative review. Scand J Trauma Resusc Emerg Med. 2016;24:48.
pubmed: 27068016
pmcid: 4828893
doi: 10.1186/s13049-016-0239-y
Shaik F, Balderstone MJM, Arokiasamy S, Whiteford JR. Roles of syndecan-4 in cardiac injury and repair. Int J Biochem Cell Biol. 2022;146: 106196.
pubmed: 35331918
doi: 10.1016/j.biocel.2022.106196
Shakeri H, Lemmens K, Gevaert AB, De Meyer GRY, Segers VFM. Cellular senescence links aging and diabetes in cardiovascular disease. Am J Physiol Heart Circ Physiol. 2018;315:H448–62.
pubmed: 29750567
doi: 10.1152/ajpheart.00287.2018
Strand ME, Vanhaverbeke M, Henkens M, Sikking MA, Rypdal KB, Braathen B, Almaas VM, Tonnessen T, Christensen G, Heymans S, Lunde IG. Inflammation and syndecan-4 shedding from cardiac cells in ischemic and non-ischemic heart disease. Biomedicines. 2023;11:1066.
pubmed: 37189684
pmcid: 10135943
doi: 10.3390/biomedicines11041066
Testa R, Olivieri F, Sirolla C, Spazzafumo L, Rippo MR, Marra M, Bonfigli AR, Ceriello A, Antonicelli R, Franceschi C, Castellucci C, Testa I, Procopio AD. Leukocyte telomere length is associated with complications of type 2 diabetes mellitus. Diabet Med. 2011;28:1388–94.
pubmed: 21692845
doi: 10.1111/j.1464-5491.2011.03370.x
Vuong TT, Reine TM, Sudworth A, Jenssen TG, Kolset SO. Syndecan-4 is a major syndecan in primary human endothelial cells in vitro, modulated by inflammatory stimuli and involved in wound healing. J Histochem Cytochem. 2015;63:280–92.
pubmed: 25575567
pmcid: 4374057
doi: 10.1369/0022155415568995
Wang X, Keith JC Jr, Struthers AD, Feuerstein GZ. Assessment of arterial stiffness, a translational medicine biomarker system for evaluation of vascular risk. Cardiovasc Ther. 2008;26:214–23.
pubmed: 18786091
doi: 10.1111/j.1755-5922.2008.00051.x
Wang XS, Yang W, Luo T, Wang JM, Jing YY. Serum endocan levels are correlated with the presence and severity of coronary artery disease in patients with hypertension. Genet Test Mol Biomarkers. 2015;19:124–7.
pubmed: 25588082
doi: 10.1089/gtmb.2014.0274
Yilmaz O, Afsar B, Ortiz A, Kanbay M. The role of endothelial glycocalyx in health and disease. Clin Kidney J. 2019;12:611–9.
pubmed: 31583086
pmcid: 6768294
doi: 10.1093/ckj/sfz042
Yousefzadeh MJ, Zhao J, Bukata C, Wade EA, McGowan SJ, Angelini LA, Bank MP, Gurkar AU, McGuckian CA, Calubag MF, Kato JI, Burd CE, Robbins PD, Niedernhofer LJ. Tissue specificity of senescent cell accumulation during physiologic and accelerated aging of mice. Aging Cell. 2020;19: e13094.
pubmed: 31981461
pmcid: 7059165
doi: 10.1111/acel.13094
Zhao J, Ye X, Zhang Z. Syndecan-4 is correlated with disease activity and serological characteristic of rheumatoid arthritis. Adv Rheumatol. 2022;62:21.
pubmed: 35725524
doi: 10.1186/s42358-022-00254-3